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ABSTRACT 
Carcinosarcoma (true malignant mixed tumor) is an extremely rare tumor of the salivary gland. It is a biphasic tumor and is 
composed of both malignant epithelial and malignant mesenchymal component. Commonly, squamous cell carcinoma and 
adenocarcinoma forms the epithelial component and chondrosarcoma forms the mesenchymal component. We, hereby, report a 
parotid lesion in a 47 year old female that contained adenocarcinoma as epithelial component and chondrosarcoma as 
mesenchymal component. We report this unusual case of carcinosarcoma of parotid gland due to its rarity. It mimics benign 
lesions on ultrasonographic examination. On fine needle aspiration, the diagnosis of carcinosarcoma can be missed, as was in 
our case where it was reported as pleomorphic adenoma with atypical features. Histopathology only gives confirmatory 
diagnosis.  In addition, a short review of literature along with possible pathogenesis of malignant mixed tumor of salivary 
gland is also presented. 
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arcinosarcoma is an extremely rare true malignant 
mixed tumor of salivary gland comprising 0.04-
0.16% of total cases. Sixty five percent of these 
tumors arise in parotid gland [1]. This heterologous 
neoplasm is composed of both malignant mesenchymal 
and epithelial components [2]. It is a high-grade neoplasm 
with multiple episodes of recurrences and blood borne 
distant metastasis [3]. The malignant epithelial component 
is mostly formed by squamous cell and adenocarcinoma. 
On the other hand, chondrosarcoma forms the most 
common malignant mesenchymal component followed by 
fibrosarcoma, leiomyosarcoma, osteosarcoma, and 
liposarcoma in decreasing order of frequency [1].  
We report a case of carcinosarcoma of the parotid 
gland in 47-year-old woman with adenocarcinoma as 
epithelial and chondrosarcoma as mesenchymal 
component, with ultrasonographic, cytological and 
histological findings. 
 
CASE REPORT 
A 47-year-old female presented to E.N.T. outpatient 
department of Narayana hospital, Nellore, with a mass just 
below the right ear lobule of 4 weeks duration with mild 
tenderness. She had no significant medical complaints. No 
history of smoking and tobacco chewing were present. On 
clinical examination, mass was measuring 1x1 cm, firm in 
consistency and located just above the angle of mandible. 
It was fixed to the underlying structures. Skin overlying 
the tumor was normal. No lymphadenopathy was present.  
Basic hematological investigations, liver function test, 
renal function tests, chest X- ray and ultrasonography 
(USG) of abdomen were normal. Provisional diagnosis of 
pleomorphic adenoma was made and fine needle aspiration 
cytology (FNAC) of the lesion was planned. 
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Figures - Fig 1- Adenocarcinoma component with malignant cells arranged in cribriform pattern (H&E X400), Fig 2- Malignant 
chondrosarcoma component (H&E X400), and Fig 3- Myxoid and hyaline change representing pre-existing pleomorphic adenoma 
FNAC slides showed clusters and dispersed individual 
malignant epithelial cells exhibiting marked nuclear 
pleomorphism, increased nuclear-cytoplasmic ratio, and 
prominent nucleoli with abundant fibromyxoid stroma and 
hyaline material in the background. Diagnosis of atypical 
pleomorphic adenoma was made. 
Because of atypical cells in FNAC, the patient was 
considered for surgery. A preoperative USG of the right 
region of the neck showed a well-defined lobulated, 
heterogeneously hypoechoic, 19 x 11 mm tumor in the 
superficial lobe of right parotid gland with minimal 
peripheral vascularity on CDFI with insignificant lymph 
nodes. The USG findings were consistent with benign 
pleomorphic adenoma. Thereafter, the patient underwent 
right total parotidectomy with full preservation of the 
facial nerve. The specimen was received and processed by 
the department of Pathology, Narayana medical college 
and hospital. It was fixed in 10% formalin, embedded in 
paraffin and routine H & E sections were obtained. 
Grossly, the parotidectomy specimen measured 
5x3x1.5cm. The cut surface revealed a relatively well-
deﬁned, grayish white tumor, firm in consistency, 
measuring 1.5x1.5x1 cm, with adjacent normal salivary 
gland parenchyma. 
 Microscopically, the tumor was mainly composed of 
two components, carcinoma and sarcoma. The former was 
that of moderately differentiated adenocarcinoma. 
Carcinomatous component is characterized by malignant 
cells arranged in sheets, cribriform pattern and glandular 
pattern (Figure 1). The sarcomatous component was 
mostly composed of chondrosarcoma (Figure 2). Large 
foci of hyalinization and myxoid change representing 
pleomorphic adenoma were present (Figure 3). Mitotic 
ﬁgures and multinucleated tumor giant cells were also 
noticed. Background consisted of areas of necrosis. Two 
regional lymph nodes were isolated, both negative for 
tumor. So, a final diagnosis of carcinosarcoma of parotid 
gland was made. Postoperative state was uneventful and 
four months follow up of the case showed good recovery. 
No metastatic deposits were detected on clinical and 
radiological investigations. 
DISCUSSION 
Malignant mixed tumor of the salivary gland is composed 
of three distinct clinical entities - carcinoma ex 
pleomorphic adenoma (the most common type), 
metastasizing mixed tumor and carcinosarcoma [3]. The 
term true malignant mixed tumor was first described by 
King et al in 1967 [4].  
The tumor genesis of carcinosarcoma is controversial 
and two hypotheses are suggested. According to some 
authors, carcinosarcoma and pleomorphic adenoma of the 
salivary gland may share a common precursor, possibly a 
myoepithelial cell (divergence hypothesis). On the other 
hand, it has been shown that in some carcinosarcomas, 
both components arise de novo (convergence hypothesis) 
[5]. In the present case, evidence of pleomorphic adenoma 
in multiple histologic sections studied, supports divergence 
hypothesis. Till now seven cases of carcinosarcoma have 
shown histologic evidence of pre-existing or co-existing 
pleomorphic adenoma [6, 7-9, 10, 11, 12].  
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Table 1 - Carcinosarcoma (True Malignant Mixed Tumors) of Salivary Glands: A review of literature 
Source, year Age/ 
Sex 
Location  Sarcomatous component Carcinomatous 
component 
Garner, 1989 [15] 57/F Parotid gland Chondrosarcoma, osteosarcoma Adenocarcinoma 
Bleiweiss, 1992 [17] 64/M Submandibular gland Osteosarcoma Ductal carcinoma 
Carson, 1995 [7] 51/F Parotid gland Osteosarcoma Adenocarcinoma 
Alvarez-Canas, 1996 [6] 64/M Parotid gland Fibrosarcoma Ductal carcinoma 
Gogas, 1999 [18] 77/M Submandibular gland Chondrosarcoma, osteosarcoma, 
rhabdomyosarcoma 
Ductal carcinoma 
 
Kwon, 2001 [19] 47/M Parotid gland Rhabdomyosarcoma, Fibrosarcoma Squamous cell carcinoma 
Owaki, 2003 [20] 71/M Submandibular gland Chondrosarcoma Myoepithelial carcinoma  
Gnepp, 1993 [1]   43 case review                   See discussion 
Present case  47/F Parotid gland Chondrosarcoma Adenocarcinoma 
 
Gnepp et al studied 43 cases of carcinosarcoma of the 
salivary glands [1]. The maximum number of these tumors 
(33%) was observed in parotid glands followed by 
submandibular glands (19%) and palate (14%). There was 
no sex predominance and the mean age at presentation was 
58 years. The histology of the epithelial component 
comprised of salivary duct carcinoma as the most common 
(19 cases), followed by adenocarcinoma (6 cases), poorly 
differentiated carcinoma (5 cases), undifferentiated 
carcinoma (4 cases), squamous cell carcinoma (3 cases), 
and epidermoid carcinoma (1 case). Focal areas of mixed 
differentiation were also present in 5 cases. In this case 
report, patient is 47 year old female. The epithelial 
component is composed of adenocarcinoma whereas 
mesenchymal component is mainly formed by 
chondrosarcoma.  
We also discuss some cases of carcinosarcoma of 
salivary gland in table 1. In the current case report, by 
cytology only carcinomatous component characterized by 
sheets of malignant epithelial cells was well noticed. 
Among mesenchymal components, only fibromyxoid and 
hyaline material were present and no sarcomatous 
component was noticed. This may be due to presence of 
focal chondrosarcoma component. Only in three reports [9, 
10, 13], cytology features of carcinosarcoma parotid have 
been studied making this case unusual and supplementary 
to the limited literature. 
 The differential diagnosis of unilateral parotid lesion 
included benign mixed tumor, primary versus metastatic 
sarcomas, carcinoma ex-pleomorphic adenoma and muco- 
 
epidermoid carcinoma. In our case, tumor cells display 
atypical features including cellular and nuclear 
pleomorphism, hyperchromatism, mitotic figures and 
invasive growth. These features help in distinguishing it 
from benign mixed tumor. Carcinoma ex-pleomorphic 
adenoma and mucoepidermoid carcinoma were excluded 
on the basis of presence of sarcomatous component. 
  USG findings and clinical examination were 
suggestive of pleomorphic adenoma. FNAC has 
contributed substantially in its preoperative diagnosis as 
atypical pleomorphic adenoma. The definitive diagnosis of 
carcinosarcoma parotid was made based on 
histopathological examination. The prognosis is 
determined by clinical and histological stage of the 
disease. The prognosis is poor with 58-85% of patients 
dying of the disease. So, there should be close follow up of 
these patients for symptoms and signs of local recurrence 
and metastasis [14-16]. 
CONCLUSION 
The reported case is a rare case of carcinosarcoma (true 
mixed malignant tumor) of the parotid gland arising from 
pre-existing pleomorphic adenoma with adenocarcinoma 
and chondrosarcoma as predominant epithelial and 
mesenchymal component respectively. The diagnosis of 
carcinosarcoma can be missed on USG examination where 
it was reported as benign lesion and fine needle aspiration 
where it was reported as pleomorphic adenoma with 
atypical features. Only histopathology is diagnostic for 
carcinosarcoma of salivary gland. 
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